# Inflammation and Stem Cells in Diabetic and Chronic Kidney Disease

> **NCT03325322** · PHASE2 · SUSPENDED · sponsor: **Mayo Clinic** · enrollment: 30 (estimated)

## Conditions studied

- Chronic Kidney Diseases
- Diabetes Mellitus
- Diabetic Nephropathies

## Interventions

- **DIETARY_SUPPLEMENT:** Fisetin
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT03325322
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2018-01-02
- **Primary completion:** 2027-01
- **Final completion:** 2027-01
- **Target enrollment:** 30 (ESTIMATED)
- **Why stopped:** Due to lack of funding
- **Last updated:** 2026-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03325322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03325322, "Inflammation and Stem Cells in Diabetic and Chronic Kidney Disease". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03325322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*